| 1 |
35132496 | Transfersome Hydrogel Containing 5-Fluorouracil and Etodolac Combination for Synergistic Oral Cancer Treatment. | 2022 Feb 7 |
2 |
| 2 |
32158956 | Comparison of safety and analgesic efficacy of diclofenac sodium with etodolac after surgical extraction of third molars: a randomized, double-blind, double-dummy, parallel-group study. | 2020 Feb |
1 |
| 3 |
30216103 | Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs. | 2019 Aug |
1 |
| 4 |
28875479 | Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac. | 2017 Nov |
3 |
| 5 |
24516579 | Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells. | 2014 |
1 |
| 6 |
22846758 | The effects of the selective cyclooxygenase-2 inhibitor on endometrial cytological findings in uterine endometrial cancer patients. | 2012 |
2 |
| 7 |
21868535 | Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase. | 2011 Sep |
2 |
| 8 |
18242386 | Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo. | 2008 Jan |
4 |
| 9 |
18405470 | Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. | 2008 Apr |
2 |
| 10 |
17143495 | Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1). | 2007 Jan |
1 |
| 11 |
17186240 | R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells. | 2007 Sep |
1 |
| 12 |
17603251 | Membranous nephropathy associated with the relatively selective cyclooxygenase-2 inhibitor, etodolac, in a patient with early rheumatoid arthritis. | 2007 |
2 |
| 13 |
16046235 | Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells. | 2006 Feb |
1 |
| 14 |
15598589 | Etodolac, a selective cyclo-oxygenase-2 inhibitor, enhances carboplatin-induced apoptosis of human tongue carcinoma cells by down-regulation of FAP-1 expression. | 2005 Jan |
2 |
| 15 |
15809736 | Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. | 2005 May |
1 |
| 16 |
15892673 | The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. | 2005 |
1 |
| 17 |
16004971 | Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. | 2005 Sep 1 |
1 |
| 18 |
16104877 | Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells. | 2005 Sep |
2 |
| 19 |
16360450 | Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo. | 2005 Dec |
4 |
| 20 |
15298730 | Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines. | 2004 Aug |
2 |
| 21 |
12607659 | Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial. | 2003 Feb |
1 |
| 22 |
12824918 | Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor. | 2003 Mar |
1 |
| 23 |
12126649 | Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. | 2002 May 7 |
1 |
| 24 |
12483244 | Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines. | 2002 |
1 |
| 25 |
11160644 | Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. | 2001 Feb |
1 |
| 26 |
11251697 | Direct superoxide scavenging activity of nonsteroidal anti-inflammatory drugs: determination by electron spin resonance using the spin trap method. | 2001 Feb |
1 |
| 27 |
11275997 | Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. | 2001 Mar 15 |
6 |
| 28 |
11525777 | Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation. | 2001 Aug 24 |
1 |
| 29 |
10594327 | Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells. | 1999 Nov 3 |
1 |
| 30 |
9481468 | Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis. | 1998 Jan |
1 |
| 31 |
8566109 | Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. | 1995 Jul 25 |
3 |